Elanco Animal Health (ELAN) EBT (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly EBT came in at $87.0 million in Q1 2026, up 45.0% year-on-year from $60.0 million in Q1 2025, and up 133.59% quarter-over-quarter from -$259.0 million in Q4 2025.
Elanco Animal Health (ELAN) EBT (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed EBT across 10 years of filings, most recently posting $87.0 million for Q1 2026.
- EBT for Q1 2026 came in at $87.0 million, up 45.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$197.0 million (down 136.75% YoY), and the FY2025 annual result was -$224.0 million, down 145.9% from the prior year.
- EBT came in at $87.0 million for Q1 2026 at Elanco Animal Health, up from -$259.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $559.0 million in Q3 2024 to a low of -$1.1 billion in Q3 2023.
- The 5-year median for EBT is -$32.0 million (2024), against an average of -$53.9 million.
- Across the five-year window, EBT tumbled 2393.18% in 2023 and soared 400.0% in 2025, its largest moves.
- Elanco Animal Health's EBT stood at -$89.0 million in 2022, then plunged by 42.7% to -$127.0 million in 2023, then soared by 59.84% to -$51.0 million in 2024, then tumbled by 407.84% to -$259.0 million in 2025, then jumped by 133.59% to $87.0 million in 2026.
- The last three EBT figures came in at $87.0 million (Q1 2026), -$259.0 million (Q4 2025), and -$50.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 437.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 758.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 318.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 17.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 246.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 87.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -61.93 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 156.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -101.55 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 56.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.00 Mn |
| Dec 31, 2025 | -259.00 Mn |
| Sep 30, 2025 | -50.00 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Mar 31, 2025 | 60.00 Mn |
| Dec 31, 2024 | -51.00 Mn |
| Sep 30, 2024 | 559.00 Mn |
| Jun 30, 2024 | -32.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | -127.00 Mn |
| Sep 30, 2023 | -1.10 Bn |
| Jun 30, 2023 | -79.00 Mn |
| Mar 31, 2023 | 108.00 Mn |
| Dec 31, 2022 | -89.00 Mn |
| Sep 30, 2022 | -44.00 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | 75.00 Mn |
| Dec 31, 2021 | -120.00 Mn |
| Sep 30, 2021 | -130.00 Mn |
| Jun 30, 2021 | -243.00 Mn |